Integer Holdings Corp (NYSE:ITGR) Receives $70.76 Consensus Price Target from Analysts

Integer Holdings Corp (NYSE:ITGR) has received a consensus recommendation of “Hold” from the five brokerages that are currently covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $60.15.

A number of research firms recently weighed in on ITGR. KeyCorp increased their price objective on shares of Integer from $97.00 to $116.00 and gave the stock an “overweight” rating in a research report on Friday, February 21st. ValuEngine raised Integer from a “sell” rating to a “hold” rating in a research report on Tuesday, December 3rd.

Shares of NYSE:ITGR traded up $0.43 during midday trading on Friday, reaching $94.64. 276,800 shares of the company’s stock were exchanged, compared to its average volume of 203,545. The stock has a market cap of $3.16 billion, a price-to-earnings ratio of 32.52 and a beta of 1.01. Integer has a fifty-two week low of $67.72 and a fifty-two week high of $99.95. The firm’s 50 day simple moving average is $89.04 and its two-hundred day simple moving average is $79.71. The company has a debt-to-equity ratio of 0.71, a current ratio of 2.32 and a quick ratio of 1.39.

Integer (NYSE:ITGR) last announced its earnings results on Thursday, February 20th. The medical equipment provider reported $1.25 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.18 by $0.07. Integer had a net margin of 7.66% and a return on equity of 13.83%. The company had revenue of $325.60 million during the quarter, compared to analyst estimates of $321.68 million. During the same quarter last year, the firm posted $1.04 earnings per share. Integer’s revenue was up 7.5% compared to the same quarter last year. Equities research analysts predict that Integer will post 5.2 earnings per share for the current fiscal year.

In other Integer news, Director Peter H. Soderberg sold 1,766 shares of the business’s stock in a transaction dated Thursday, December 5th. The shares were sold at an average price of $79.24, for a total transaction of $139,937.84. Insiders own 2.24% of the company’s stock.

Several institutional investors have recently bought and sold shares of the company. Profund Advisors LLC grew its position in shares of Integer by 3.8% in the 4th quarter. Profund Advisors LLC now owns 3,523 shares of the medical equipment provider’s stock valued at $283,000 after buying an additional 128 shares during the last quarter. Texas Permanent School Fund lifted its position in Integer by 0.6% in the fourth quarter. Texas Permanent School Fund now owns 22,353 shares of the medical equipment provider’s stock valued at $1,798,000 after acquiring an additional 133 shares during the last quarter. Municipal Employees Retirement System of Michigan lifted its position in Integer by 2.0% in the fourth quarter. Municipal Employees Retirement System of Michigan now owns 9,990 shares of the medical equipment provider’s stock valued at $803,000 after acquiring an additional 200 shares during the last quarter. Mercer Global Advisors Inc. ADV lifted its position in Integer by 8.1% in the fourth quarter. Mercer Global Advisors Inc. ADV now owns 3,165 shares of the medical equipment provider’s stock valued at $255,000 after acquiring an additional 236 shares during the last quarter. Finally, Mason Street Advisors LLC boosted its stake in Integer by 2.7% in the fourth quarter. Mason Street Advisors LLC now owns 11,382 shares of the medical equipment provider’s stock valued at $915,000 after acquiring an additional 297 shares in the last quarter. 97.83% of the stock is currently owned by institutional investors and hedge funds.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates in two segments, Medical and Non-Medical. The company offers products for vascular, cardiac surgery, and structural heart diseases; peripheral vascular, neurovascular, urology, and oncology products; and electrophysiology, infusion therapy, and hemodialysis products.

Further Reading: What is a back-end load?

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.